The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Understanding the genetic mechanisms linking genome variations, such as single-nucleotide polymorphisms (SNPs), to phenotypes is challenging. Quantitative trait loci (QTLs) are genomic loci that ...

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by ...

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

Nuclera, the biotechnology company providing rapid access to functional proteins for drug discovery, has completed its first installations in Asia. Systems are now operational at the National ...

Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...